NVO
Stock Details
NVO is Novo Nordisk A/S's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 142.29$. Average daily volumn in 3 months 1.43M. Market cap 359.34B
Stock symbol : NVO. Exchange : NYSE. Currency : USD Lastest price : 158.09$. Total volume : 1.02M. Market state POST Click reload if you want to check the lastest price on market!!!
Novo Nordisk A/S (NVO)
Last Price
158.09$Change
1.51Volume
1.02M
| Previous Close | 156.58 |
| Open | 157.23 |
| Day Range | 157.06-158.11 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Volume | 1.02M |
| Average Volume | 1.43M |
| Market Cap | 359.34B |
| Beta | 0.31 |
| 52 Week Range | 95.02-158.11 |
| Trailing P/E | 44.66 |
| Foward P/E | 30.40 |
| Dividend (Yield %) | 1.14% |
| Ex-Dividend Date | 2023-03-24 |
Financial Details
Organization
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormon... e replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Market Cap:
359.34BRevenue:
176.95BTotal Assets:
241.26BTotal Cash:
12.65B
News about "Novo Nordisk A/S"
Novo Nordisk A/S (NVO) Shares Down Despite Recent Market Volatility
Source from : newsheater - 7 days ago
Novo Nordisk A/S (NYSE: NVO)’s stock price has decreased by -0.41 compared to its previous closing price of 147.29. Nevertheless, the company has seen a gain of 4.05% in its stock price over the last ...See details»
Novo Nordisk A/S - share repurchase programme
Source from : Yahoo Finance - 3 days ago
Bagsværd, Denmark, 27 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and ...See details»
NVO Novo Nordisk A/S
Source from : Seeking Alpha - 3 days ago
**NM signifies a non meaningful value. A dash signifies the data is not available.See details»
Novo Nordisk A/S Series B
Source from : Wall Street Journal - 17 days ago
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»
Novo Nordisk A/S: Trading In Novo Nordisk Shares By Board Members, Executives And Associated Persons
Source from : Mena FN - 1 month ago
Bagsværd, Denmark, 8 February 2023 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated ...See details»
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Source from : Benzinga.com - 7 days ago
Bagsværd, Denmark, 23 March 2023 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, Chair of the Board of Directors communicated: "We are very ...See details»
Novo Nordisk A/S: Novo Nordisk to expand R&D presence in greater Boston area
Source from : Finanznachrichten - 28 days ago
This new hub, which will leverage the company's existing presence in Lexington, Cambridge and Watertown, Massachusetts, will be home to the majority of Novo Nordisk's US-based research and ...See details»
Novo Nordisk: Regarding FY22 And The Serendipity Of GLP-1s
Source from : Seeking Alpha - 6 days ago
The purpose of this article is chiefly to use Novo Nordisk's FY22 as a springboard for longer term considerations to the NVO investment case, such as strategy and pipelines. First, it is ...See details»
Novo Nordisk (NVO) Receives a Buy from Bank of America Securities
Source from : Business Insider - 5 days ago
Bank of America Securities analyst Sachin Jain maintained a Buy rating on Novo Nordisk (NVO – Research Report) yesterday and set a price target of $174.00. The company’s shares closed ...See details»
Obesity Drug Hit Makes Novo Nordisk More Valuable Than Nestle
Source from : YAHOO!News - 6 days ago
It’s the Wegovy effect. Most Read from BloombergJack Dorsey’s Block Vows to Fight Back After Hindenburg Says It’s Short the StockUBS Sends Khan to Stem Credit Suisse’s Private Banker ExitsCredit ...See details»
Novo Nordisk A/S - Share Repurchase Programme
Source from : Mena FN - 3 days ago
Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com , facebook , twitter ...See details»
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Source from : Yahoo! Sports - 7 days ago
Bagsværd, Denmark, 23 March 2023 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, Chair of the Board of Directors communicated: “We are very ...See details»
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Source from : Yahoo Movies UK - 1 month ago
Bagsværd, Denmark, 7 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated ...See details»
Novo Nordisk A/S – Share repurchase programme
Source from : Yahoo - 1 month ago
Bagsværd, Denmark, 27 February 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...See details»